↓ Skip to main content

Gene Therapy of Solid Cancers

Overview of attention for book
Cover of 'Gene Therapy of Solid Cancers'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy
  3. Altmetric Badge
    Chapter 2 Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor Model.
  4. Altmetric Badge
    Chapter 3 MIDGE Technology for the Production of a Fourfold Gene-Modified, Allogenic Cell-Based Vaccine for Cancer Therapy.
  5. Altmetric Badge
    Chapter 4 Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis
  6. Altmetric Badge
    Chapter 5 Oncoleaking: Use of the Pore-Forming Clostridium perfringens Enterotoxin (CPE) for Suicide Gene Therapy
  7. Altmetric Badge
    Chapter 6 iCaspase 9 Suicide Gene System.
  8. Altmetric Badge
    Chapter 7 p53-Encoding pDNA Purification by Affinity Chromatography for Cancer Therapy
  9. Altmetric Badge
    Chapter 8 A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimic.
  10. Altmetric Badge
    Chapter 9 Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors.
  11. Altmetric Badge
    Chapter 10 RNA Interference for Antimetastatic Therapy
  12. Altmetric Badge
    Chapter 11 STAT3 Decoy ODN Therapy for Cancer.
  13. Altmetric Badge
    Chapter 12 Oncolytic Viral Therapy Using Reovirus
  14. Altmetric Badge
    Chapter 13 Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring
  15. Altmetric Badge
    Chapter 14 Back to the Future: Are Tumor-Targeting Bacteria the Next-Generation Cancer Therapy? - PubMed - NCBI
  16. Altmetric Badge
    Chapter 15 Ethics of Cancer Gene Transfer Clinical Research
  17. Altmetric Badge
    Chapter 16 Planning an Academic Clinical Trial
  18. Altmetric Badge
    Chapter 17 Production of Plasmid DNA as Pharmaceutical
  19. Altmetric Badge
    Chapter 18 Minicircle: Next Generation DNA Vectors for Vaccination.
  20. Altmetric Badge
    Chapter 19 A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma.
  21. Altmetric Badge
    Chapter 20 Antiangiogenic Metargidin Peptide (AMEP) Gene Therapy in Disseminated Melanoma.
  22. Altmetric Badge
    Chapter 21 Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid Tumors.
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
11 X users
patent
1 patent

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gene Therapy of Solid Cancers
Published by
Springer New York, June 2015
DOI 10.1007/978-1-4939-2727-2
ISBNs
978-1-4939-2726-5, 978-1-4939-2727-2
Editors

Walther, Wolfgang, Stein, Ulrike

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 22%
Researcher 5 11%
Student > Master 4 9%
Student > Doctoral Student 3 7%
Student > Ph. D. Student 2 4%
Other 4 9%
Unknown 18 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 24%
Agricultural and Biological Sciences 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Medicine and Dentistry 3 7%
Chemical Engineering 1 2%
Other 5 11%
Unknown 20 43%